Ferredoxin Reductase Antikörper (AA 33-451)
Kurzübersicht für Ferredoxin Reductase Antikörper (AA 33-451) (ABIN7161027)
Target
Alle Ferredoxin Reductase (FDXR) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 33-451
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human NADPH:adrenodoxin oxidoreductase, mitochondrial protein (33-451AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Ferredoxin Reductase (FDXR)
-
Andere Bezeichnung
- FDXR
-
Hintergrund
-
Background: Serves as the first electron transfer protein in all the mitochondrial P450 systems. Including cholesterol side chain cleavage in all steroidogenic tissues, steroid 11-beta hydroxylation in the adrenal cortex, 25-OH-vitamin D3-24 hydroxylation in the kidney, and sterol C-27 hydroxylation in the liver.
Aliases: Adrenodoxin reductase antibody, ADRO_HUMAN antibody, ADXR antibody, AR antibody, FDXR antibody, Ferredoxin NADP(+) reductase antibody, Ferredoxin reductase antibody, Ferredoxin--NADP(+) reductase antibody, mitochondrial antibody, NADPH adrenodoxin oxidoreductase mitochondrial antibody, NADPH:adrenodoxin oxidoreductase antibody
-
UniProt
- P22570
Target
-